BioCryst Pharmaceuticals | BCRX - 판매 매출 총 이익





판매 매출 총 이익 변화 날짜
Alnylam Pharmaceuticals USD 992.69M 167.68M 2026-06
BioCryst Pharmaceuticals USD 214.41M 61.36M 2026-06
Chugai Pharma JPY 237.37B 21.38B 2026-06
Daiichi Sankyo JPY 287.15B 152.68B 2026-03
DBV Technologies USD 2.77M 33.21M 2025-09
Enanta Pharmaceuticals -22.29M 23.75M 2024-12
Gilead Sciences USD 6.8B 1.29B 2026-06
GlaxoSmithKline GBP 6.51B 757M 2026-06
Glaxosmithkline GBP 5.75B 2.99B 2026-03
Incyte USD 1.57B 400.89M 2026-06
Ionis Pharmaceuticals USD 265M 22M 2026-06
Karyopharm Therapeutics USD 33.72M 1.13M 2026-03
Neurocrine Biosciences USD 800.7M 12.8M 2026-03
Novavax USD 125.04M 76.09M 2025-12
PTC Therapeutics USD 232.94M 84.56M 2026-03
Regeneron Pharmaceuticals USD 3.71B 778.2M 2026-06
Roche Holding CHF 22.69B 600M 2026-06
Sarepta Therapeutics USD 251.15M 370.2M 2026-06
Ultragenyx Pharmaceutical USD 180M 74M 2026-06
Vertex Pharmaceuticals USD 2.84B 242.4M 2026-06